Zobrazeno 1 - 10
of 131
pro vyhledávání: '"R. B. Colvin"'
Autor:
R I Kushak, D C Boyle, I A Rosales, J R Ingelfinger, G L Stahl, M Ozaki, R B Colvin, E F Grabowski
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0220483 (2019)
E. coli associated Hemolytic Uremic Syndrome (epidemic hemolytic uremic syndrome, eHUS) caused by Shiga toxin-producing bacteria is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury that cause acute renal f
Externí odkaz:
https://doaj.org/article/4fc9251d1b8d455288bdaf2592e3da63
Autor:
W. Sommer, J. M. O□, K. B. Pruner, A. Bean, A. Dehnadi, I. Hanekamp, R. B. Colvin, G. Benichou, T. Kawai, J. C. Madsen
Publikováno v:
The Thoracic and Cardiovascular Surgeon.
Publikováno v:
The Journal of Immunology. 155:3674-3682
An anti-CD3:anti-CD25 (CD3,25) bispecific mAb was developed with the objective of combining the advantages of the parent anti-CD3 and anti-CD25 mAbs. The in vivo effects of the CD3,25 were examined in comparison to the parent Abs. The CD3,25 was well
Publikováno v:
The Journal of Immunology. 152:5135-5141
Obstructive lesions in arterial vessels of transplanted organs constitute an important factor in the late failure of these organs, especially for the heart. The absence of obstructive lesions in syngeneic donor-recipient combinations, suggests that t
Publikováno v:
The Journal of Immunology. 150:1619-1628
T cells are major mediators of graft rejection and many autoimmune diseases. During the Ag recognition process, T cells often become activated. We tested the hypothesis that an anti-CD3:anti-CD25 (CD3,25) bispecific mAb (BSMAB) can effectively and se
Publikováno v:
The Journal of Immunology. 144:4604-4612
These studies test whether allograft rejection can be blocked by interference with leukocyte adhesion, using a murine IgG2a mAb (R6.5) reactive with monkey ICAM-1 (CD54). In 16 Cynomolgus renal allograft recipients, R6.5 was administered prophylactic
Autor:
M, Pascual, N, Tolkoff-Rubin, M L, Farrell, W, Williams, H, Auchincloss, D, Ko, S, Saidman, R B, Colvin, A B, Cosimi, F L, Delmonico
Publikováno v:
Clinical transplants.
Between February 1963 and December 2000, 1,627 kidney transplants were performed at the Massachusetts General Hospital. The majority (62%) were from cadaveric donors, although in recent years (1996-2000) 52% have been allografts from living donors, w
Autor:
T, Kawai, H, Sogawa, M, Koulmanda, R N, Smith, J J, O'Neil, S L, Wee, S, Boskovic, M, Sykes, R B, Colvin, D H, Sachs, H, Auchincloss, A B, Cosimi, D S, C Ko
Publikováno v:
Transplantation. 72(2)
Development of mixed chimerism by donor bone marrow transplantation (DBMT) has led to long-term tolerance of solid organ allografts in nonhuman primates. As an initial attempt to extend this approach to cellular transplant, islet transplant from the
Autor:
T P, Theruvath, S L, Saidman, S, Mauiyyedi, F L, Delmonico, W W, Williams, N, Tolkoff-Rubin, A B, Collins, R B, Colvin, A B, Cosimi, M, Pascual
Publikováno v:
Transplantation. 72(1)
In renal transplantation, chronic rejection is a major cause of late allograft loss. Recent studies indicate that a subset of chronic rejection is associated with anti-HLA donor specific antibodies (DSA) and complement C4d deposition in peritubular c
Autor:
M, Crespo, M, Pascual, N, Tolkoff-Rubin, S, Mauiyyedi, A B, Collins, D, Fitzpatrick, M L, Farrell, W W, Williams, F L, Delmonico, A B, Cosimi, R B, Colvin, S L, Saidman
Publikováno v:
Transplantation. 71(5)
Acute rejection (AR) associated with de novo production of donor-specific antibodies (DSA) is a clinicopathological entity that carries a poor prognosis (acute humoral rejection, AHR). The aim of this study was to determine the incidence and clinical